Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system
- PMID: 15673758
- PMCID: PMC547327
- DOI: 10.1128/AAC.49.2.733-740.2005
Novel Plasmodium vivax dhfr alleles from the Indonesian Archipelago and Papua New Guinea: association with pyrimethamine resistance determined by a Saccharomyces cerevisiae expression system
Abstract
In plasmodia, the dihydrofolate reductase (DHFR) enzyme is the target of the pyrimethamine component of sulfadoxine-pyrimethamine (S/P). Plasmodium vivax infections are not treated intentionally with antifolates. However, outside Africa, coinfections with Plasmodium falciparum and P. vivax are common, and P. vivax infections are often exposed to S/P. Cloning of the P. vivax dhfr gene has allowed molecular comparisons of dhfr alleles from different regions. Examination of the dhfr locus from a few locations has identified a very diverse set of alleles and showed that mutant alleles of the vivax dhfr gene are prevalent in Southeast Asia where S/P has been used extensively. We have surveyed patient isolates from six locations in Indonesia and two locations in Papua New Guinea. We sequenced P. vivax dhfr alleles from 114 patient samples and identified 24 different alleles that differed from the wild type by synonymous and nonsynonymous point mutations, insertions, or deletions. Most importantly, five alleles that carried four or more nonsynonymous mutations were identified. Only one of these highly mutant alleles had been previously observed, and all carried the 57L and 117T mutations. P. vivax cannot be cultured continuously, so we used a yeast assay system to determine in vitro sensitivity to pyrimethamine for a subset of the alleles. Alleles with four nonsynonymous mutations conferred very high levels of resistance to pyrimethamine. This study expands significantly the total number of novel dhfr alleles now identified from P. vivax and provides a foundation for understanding how antifolate resistance arises and spreads in natural P. vivax populations.
Figures


Similar articles
-
Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.Antimicrob Agents Chemother. 2007 Mar;51(3):857-63. doi: 10.1128/AAC.01200-06. Epub 2006 Dec 28. Antimicrob Agents Chemother. 2007. PMID: 17194833 Free PMC article.
-
Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase.Malar J. 2008 Apr 28;7:72. doi: 10.1186/1475-2875-7-72. Malar J. 2008. PMID: 18442404 Free PMC article.
-
Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine.J Infect Dis. 2004 Feb 15;189(4):744-50. doi: 10.1086/381397. Epub 2004 Feb 4. J Infect Dis. 2004. PMID: 14767830
-
Antifolates can have a role in the treatment of Plasmodium vivax.Trends Parasitol. 2007 May;23(5):213-22. doi: 10.1016/j.pt.2007.03.002. Epub 2007 Mar 26. Trends Parasitol. 2007. PMID: 17368986 Review.
-
Phylogenetic analysis suggests single and multiple origins of dihydrofolate reductase mutations in Plasmodium vivax.Acta Trop. 2021 Mar;215:105821. doi: 10.1016/j.actatropica.2020.105821. Epub 2021 Jan 3. Acta Trop. 2021. PMID: 33406444 Review.
Cited by
-
Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat.Malar J. 2015 Apr 8;14:146. doi: 10.1186/s12936-015-0660-0. Malar J. 2015. PMID: 25889875 Free PMC article.
-
Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.Antimicrob Agents Chemother. 2007 Mar;51(3):857-63. doi: 10.1128/AAC.01200-06. Epub 2006 Dec 28. Antimicrob Agents Chemother. 2007. PMID: 17194833 Free PMC article.
-
Plasmodium genomics: an approach for learning about and ending human malaria.Parasitol Res. 2019 Jan;118(1):1-27. doi: 10.1007/s00436-018-6127-9. Epub 2018 Nov 6. Parasitol Res. 2019. PMID: 30402656 Review.
-
Prevalence of polymorphisms in antifolate drug resistance molecular marker genes pvdhfr and pvdhps in clinical isolates of Plasmodium vivax from Kolkata, India.Antimicrob Agents Chemother. 2014;58(1):196-200. doi: 10.1128/AAC.01171-13. Epub 2013 Oct 21. Antimicrob Agents Chemother. 2014. PMID: 24145518 Free PMC article.
-
Distribution of Mutations Associated with Antifolate and Chloroquine Resistance among Imported Plasmodium vivax in the State of Qatar.Am J Trop Med Hyg. 2017 Dec;97(6):1797-1803. doi: 10.4269/ajtmh.17-0436. Epub 2017 Sep 28. Am J Trop Med Hyg. 2017. PMID: 29016333 Free PMC article.
References
-
- Baird, J. K., M. F. Sustriayu Nalim, H. Basri, S. Masbar, B. Leksana, E. Tjitra, R. M. Dewi, M. Khairani, and F. S. Wignall. 1996. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 90:409-411. - PubMed
-
- Barcus, M. J., Krisin, I. R. Elyazar, H. Marwoto, T. L. Richie, H. Basri, I. Wiady, D. J. Fryauff, J. D. Maguire, M. J. Bangs, and J. K. Baird. 2003. Primary infection by Plasmodium falciparum or P. vivax in a cohort of Javanese migrants to Indonesian Papua. Ann. Trop. Med. Parasitol. 97:565-574. - PubMed
-
- Barcus, M. J., F. Laihad, M. Sururi, P. Sismadi, H. Marwoto, M. J. Bangs, and J. K. Baird. 2002. Epidemic malaria in the Menoreh Hills of Central Java. Am. J. Trop. Med. Hyg. 66:287-292. - PubMed
-
- Bloland, P., S. Kachur, and H. Williams. 2003. Trends in antimalarial drug deployment in sub-Saharan Africa. J. Exp. Biol. 206:3761-3769. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources